ArticleInternational ophthalmology2026
Egyptian consensus guidance for diagnosis of adults with non-infectious uveitis.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo develop the Egyptian consensus diagnostic guidance for adult non-infectious uveitis (NIU), taking into consideration the regional epidemiologic patterns and healthcare resources.
methodsA modified three-round Delphi process was conducted from January to May 2024. A multidisciplinary committee of uveitis specialists, rheumatologists, and internists formulated 24 statements across eight diagnostic domains. Experts ranked statements using a 5-point Likert scale, with consensus defined as ≥ 75% agreement, a median score ≥ 4, and an interquartile range (IQR) ≤ 1.
resultsA total of 26 experts participated in the first round, with 21 and 18 experts completing the second and third rounds, respectively (69.2% overall retention). The panel achieved consensus on all 24 diagnostic statements, emphasizing standardized examination and SUN-based inflammation grading. The panel endorsed a stepwise cost-effective systemic workup, mandating the exclusion of tuberculosis and syphilis in all adults and utilizing chest imaging (CXR/HRCT) as a baseline. MRI brain/orbit with gadolinium contrast was advised for selected cases. OCT and fluorescein angiography were recommended baseline imaging for posterior and panuveitis, while ocular sampling (aqueous or vitreous) was reserved for atypical or resistant cases. Disease description should follow SUN anatomical classification, and sight-threatening uveitis was defined by severe or prolonged inflammation that could permanently affect vision.
conclusionsThis multidisciplinary consensus provides a structured, evidence-driven framework for uveitis diagnosis tailored to the Egyptian clinical and epidemiological context. It aims to standardize local practice while aligning with international standards. Broader applicability requires local adaptation and validation.
Indexed as
Identifiers
42584718What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.